Biomimetic Chemical Sensing by Fluorescence Signals Using a Virus-like Particle-Based Platform

被引:2
|
作者
Kushida, Yuki [1 ,3 ]
Arai, Yoshiyuki [1 ,2 ]
Shimono, Ken [3 ]
Nagai, Takeharu [1 ,2 ]
机构
[1] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Inst Sci & Ind Res, Dept Biomol Sci & Engn, 8-1 Mihogaoka, Ibaraki 5670047, Japan
[3] Panasonic Corp, Adv Res Div, Sora Ku, 3-4 Hikaridai, Kyoto 6190237, Japan
来源
ACS SENSORS | 2018年 / 3卷 / 01期
关键词
chemical sensor; virus-like particle; Ca2+ indicator; ligand-gated ion channel; biomimetic sensor; RECEPTOR; PROTEINS; CA2+; EXPRESSION; INDICATORS; CHANNELS; HIV-1; GAG;
D O I
10.1021/acssensors.7b00537
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The chemical receptors present in living organisms are promising tools for developing biomimetic chemical sensors. However, these receptors require lipid membranes for functioning under physiological conditions, which prevents their utilization in the production of cell-free in vitro chemical sensing systems. Here, we report the development of a cell-free biomimetic sensing platform using virus-like particles (VLPs) with intact ligand-gated Ca2+ channels and genetically encoded Ca2+ indicator (GECI). We observed that targeting GECI to the plasma membrane was essential for efficient loading GECI in the VLPs. Although the physiological Ca2+ concentration [Ca2+] maintained in the cells was low (similar to 10 nM), the concentration in the VLPs was high. This prevented the detection of the increase in [Ca2+] caused by binding of the ligand to the receptor. To address this problem, we employed Lyn-R-CEPIA1, which had low affinity for Ca2+, and a membrane targeting sequence. Thus, we succeeded in monitoring the activation of cyclic nucleotide-gated channels (CNG) on the VLPs by measuring the increase in fluorescence of Lyn-R-CEPIA1. Our VLP-based sensing system can act as a fundamental platform for all kinds of ligand-gated channels.
引用
下载
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [31] Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection
    Tang, Jielin
    Fu, Muqing
    Xu, Chonghui
    Xue, Bao
    Zhou, Anqi
    Chen, Sijie
    Zhao, He
    Zhou, Yuan
    Chen, Jizheng
    Yang, Qi
    Chen, Xinwen
    VIROLOGICA SINICA, 2023, 38 (05) : 767 - 777
  • [32] Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
    Warfield, Kelly L.
    Swenson, Dana L.
    Olinger, Gene G.
    Kalina, Warren V.
    Aman, M. Javad
    Bavari, Sina
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 : S430 - S437
  • [33] Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus
    Li, TC
    Zhang, J
    Shinzawa, H
    Ishibashi, M
    Sata, M
    Mast, EE
    Kim, K
    Miyamura, T
    Takeda, N
    JOURNAL OF MEDICAL VIROLOGY, 2000, 62 (03) : 327 - 333
  • [34] Biomimetic Design of Affinity Peptide Ligand for Capsomere of Virus-Like Particle
    Li, Yanying
    Liu, Xiaodan
    Dong, Xiaoyan
    Zhang, Lin
    Sun, Yan
    LANGMUIR, 2014, 30 (28) : 8500 - 8508
  • [35] Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
    Yadav, Rashi
    Zhai, Lukai
    Tumban, Ebenezer
    VIRUSES-BASEL, 2020, 12 (01):
  • [36] A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases
    Sharifzadeh, Mohammad
    Mottaghi-Dastjerdi, Negar
    Raad, Mohammad Soltany Rezae
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01):
  • [37] Plant production of a virus-like particle-based vaccine candidate against porcine reproductive and respiratory syndrome
    VanderBurgt, Jordan T. T.
    Harper, Ondre
    Garnham, Christopher P. P.
    Kohalmi, Susanne E. E.
    Menassa, Rima
    FRONTIERS IN PLANT SCIENCE, 2023, 14
  • [38] A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
    Mohsen, Mona O.
    Balke, Ina
    Zinkhan, Simon
    Zeltina, Villija
    Liu, Xuelan
    Chang, Xinyue
    Krenger, Pascal S.
    Plattner, Kevin
    Gharailoo, Zahra
    Vogt, Anne-Cathrine S.
    Augusto, Gilles
    Zwicker, Marianne
    Roongta, Salony
    Rothen, Dominik A.
    Josi, Romano
    da Costa, Joana J.
    Sobczak, Jan M.
    Nonic, Aleksandra
    Brand, Lee-Anne
    Nuss, Katja
    Martina, Byron
    Speiser, Daniel E.
    Kuendig, Thomas
    Jennings, Gary T.
    Walton, Senta M.
    Vogel, Monique
    Zeltins, Andris
    Bachmann, Martin F.
    ALLERGY, 2022, 77 (01) : 243 - 257
  • [39] Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
    Zhou, Fangbin
    Zhang, Dongmei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Inter- and Intralaboratory Comparison of JC Polyomavirus Antibody Testing Using Two Different Virus-Like Particle-Based Assays
    Kardas, Piotr
    Sadeghi, Mohammadreza
    Weissbach, Fabian H.
    Chen, Tingting
    Hedman, Lea
    Auvinen, Eeva
    Hedman, Klaus
    Hirsch, Hans H.
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (11) : 1581 - 1588